+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Lovastatin

BP3441
75330-75-5
98%
Biopurify
Lovastatin is an inhibitor of HMG-CoA reductase with IC50 of 3.4 nM in a cell-free assay, has a direct cellular effect independent of a cholesterol-lowering effect and delays the onset and progression of diabetic nephropathy. It has a potential application to treat PD via antioxidant effect, and it promotes fibrosis and epithelial to mesenchymal transition, by regulating the production of CCN2 in human gingival fibroblasts. Lovastatin is a fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as an anticholesteremic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom). It has a role as an antineoplastic agent, an anticholesteremic drug, a prodrug and an Aspergillus metabolite.
Catalog No Package Original Price Price Inventory Quantity Operating
BP3441-100mg 100mg
BP3441-1000mg 1000mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

NOS3 BACE1 BCL2 RELA HMGCR PPARG MMP9 APOE MTOR
NOS3 HMGCR MMP9 VEGFA MTOR
CETP HMGCR LDLR APOB APOE PPARA

Lovastatin Related Products

Product drug property prediction parameters

  • 72.8300

  • 4.2845

  • 4.2848

  • .0292

  • 3.0145

  • 3.1755

  • High

  • 90.1714

  • 4.6903

  • No

  • Yes

  • No

  • No

  • No

  • Yes

  • 0.0

  • No

  • Yes

  • Yes

  • Yes